In silico discovery of CETP inhibitors from ZINC15 compounds using docking, ADMET filtering, and molecular dynamics simulations
Kimia Mohammadi, Mojgan Nejabat, Forough Mirabi, Amirhossein Sahebkar, Farzin Hadizadeh · 2026
Read In silico discovery of CETP inhibitors from ZINC15 compounds using docking, ADMET filtering, and molecular dynamics simulations by Kimia Mohammadi, Mojgan Nejabat, Forough Mirabi, Amirhossein Sahebkar, Farzin Hadizadeh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13441038.txt.
Description
Kimia Mohammadi and colleagues screen a public compound library on computer for safer blockers of a cholesterol-shuttling protein, reporting in 2026. The protein, CETP, moves cholesterol between blood particles and remains a tempting heart-disease target. Earlier blockers stumbled on side effects, most famously torcetrapib. Their pipeline filtered natural compounds from the ZINC15 database through drug-likeness rules, safety and metabolism predictions, docking into the protein, and motion simulations of the bound complexes.
Calebin, a turmeric compound, came out on top. Its docking grip on CETP nearly matched curcumin and approached the old reference drug, while simulations showed the bound pair staying as steady as the reference complex. The authors stress that the result is computational only. Bench proof-of-concept work must confirm whether calebin truly blocks the protein before any drug hopes are warranted.
Catalog record
| CREATOR | Kimia Mohammadi, Mojgan Nejabat, Forough Mirabi, Amirhossein Sahebkar, Farzin Hadizadeh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |